The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors

Convalescent plasma therapy has been described as an attractive approach to treat critically ill patients with COVID-19 (Coronavirus disease 2019). The selection of convalescent plasma donors (CPD) is commonly based on neutralizing antibody titer. A better understanding of the quality of immune resp...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Marie Kroemer, Laura Boullerot, Mélanie Ramseyer, Laurie Spehner, Christophe Barisien, Eleonore Gravelin, Adeline Renaudin, Fabrice Cognasse, Pierre Gallian, Olivier Hermine, Karine Lacombe, Pierre Tiberghien, Olivier Adotévi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-03-01
coleção:	Frontiers in Public Health
Assuntos:	neutralizing antibodies COVID-19 COVID-19 serotherapy T cell t-lymphocyte
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fpubh.2022.816848/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!